Announced
Completed
Synopsis
Certara, a company that accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development, completed the acquisition of Applied BioMath, a company providing model-informed drug discovery and development support to help accelerate and de-risk therapeutic research and development. Financial terms were not disclosed. “Together, Applied BioMath and Certara have the scientific and computational expertise to industrialize QSP biosimulation methods. Our respective QSP businesses are complementary with regards to clients, geographic location, indications and expertise. Additionally, Certara’s existing biosimulation and AI portfolios serve as accelerators for the combined team making QSP more widely available and accessible across the industry,” William F Feehery, Certara CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.